Click on each section you wish to purchase
Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
Executive Summary
Summary
OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company's clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis of antibiotic resistance, and detection of pathogens in blood cultures. OpGen's develops products that includes QuickFISH, and PNA FISH products, Acuitas products, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.
OpGen Inc (OPGN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OpGen Inc, Medical Equipment, Deal Details 12
Venture Financing 12
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises USD 12 Million In Series B-1 Venture Financing 15
OpGen Raises USD 2 Million In Venture Financing 16
AdvanDx Raises USD 2 Million In Venture Financing 17
OpGen Raises Additional USD 2.6 Million In Series C Financing 18
OpGen Raises Additional USD1.4 Million in Venture Financing 20
Partnerships 21
OpGen Enters into Research Agreement with Merck 21
OpGen Enters into Co-Development Agreement with Fluidigm 22
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23
OpGen Enters Into Co-Development Agreement With In-Q-Tel 24
Equity Offering 25
OpGen Raises USD12 Million in Public Offering of Units 25
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29
OpGen Raises USD17 Million in IPO 31
Debt Offering 33
OpGen Raises USD0.5 Million in Debt Financing 33
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34
Acquisition 35
OpGen Acquires AdvanDx 35
OpGen Inc-Key Competitors 36
OpGen Inc-Key Employees 37
OpGen Inc-Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Aug 02, 2018: Opgen announces second quarter 2018 financial results 39
May 08, 2018: OpGen Announces First Quarter 2018 Financial Results 41
Mar 15, 2018: OpGen Announces Fourth Quarter and Full Year 2017 Financial Results 43
Nov 07, 2017: OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update 45
Aug 08, 2017: OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update 47
Apr 26, 2017: OpGen Announces 2017 First Quarter Financial Results 49
Mar 23, 2017: OpGen Announces 2016 Fourth Quarter and Year End Financial Results 50
Jan 26, 2017: OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results 51
Corporate Communications 53
Apr 27, 2017: OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors 53
Legal and Regulatory 54
Feb 05, 2018: OpGen Regains Compliance With Nasdaq Listing Requirements 54
Product News 55
Feb 01, 2018: OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies 55
Apr 12, 2017: OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 56
Feb 14, 2017: OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting 58
Other Significant Developments 59
Mar 13, 2018: OpGen Announces Collaborator in Verification Study for Acuitas Test 59
Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 60
Jun 15, 2017: OpGen's Acuitas Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
List of Figures
OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Tables
OpGen Inc, Medical Equipment, Key Facts, 2017 2
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Deals By Market, 2012 to YTD 2018 9
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises USD 12 Million In Series B-1 Venture Financing 15
OpGen Raises USD 2 Million In Venture Financing 16
AdvanDx Raises USD 2 Million In Venture Financing 17
OpGen Raises Additional USD 2.6 Million In Series C Financing 18
OpGen Raises Additional USD1.4 Million in Venture Financing 20
OpGen Enters into Research Agreement with Merck 21
OpGen Enters into Co-Development Agreement with Fluidigm 22
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23
OpGen Enters Into Co-Development Agreement With In-Q-Tel 24
OpGen Raises USD12 Million in Public Offering of Units 25
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29
OpGen Raises USD17 Million in IPO 31
OpGen Raises USD0.5 Million in Debt Financing 33
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34
OpGen Acquires AdvanDx 35
OpGen Inc, Key Competitors 36
OpGen Inc, Key Employees 37
OpGen Inc, Subsidiaries 38
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
OpGen Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
For Regular updates on our latest research reports
Compare
|
|
| Details | |
| Date | |
| January 1970 | January 1970 |
| Pages | |
| Price | |
| USD | USD |
| Companies Covered | |
| Products | |
| Publisher | |
| Discount Offer | |
| - | - |
| Download TOC | Scope | LOF | LOT | |
 |
|
| 
